Novo Nordisk has terminated its partnership with telehealth company Hims & Hers, citing serious concerns over the company’s promotion and sale of compounded, unauthorised versions of the weight loss ...

The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations ...

Novo Nordisk ends partnership with Hims & Hers over compounded Wegovy, shaking the market. See why I recommend a wait-and-see ...

The combination offers a potential solution to one of the key problems that’s emerged with popular obesity shots.